Home
Conditions
Acute Myeloid Leukemia (AML)

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Not yet recruiting

Improving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia

NCT07777471

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Not yet recruiting

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

NCT07780565

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

NCT07686965

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematopoetic Stem Cell Transplantation, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.

NCT07642453

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

VAH vs VA in Newly Diagnosed Elderly AML

NCT07469046

Conditions: Acute Myeloid Leukemia (AML), Elderly Patients (60-75 Years), Hematologic Diseases, +6 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

NCT07507825

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

NCT07505160

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

NCT07486726

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Shanghai Jing'an District Beizhan Hospital Shanghai, China

Shanghai Traditional Chinese Medicine Hospital Shanghai, China

Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Not yet recruiting

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

NCT07060001

Conditions: Acute Myeloid Leukaemia (AML), Acute Myeloid Leukemia (AML), Hematologic Diseases, +6 more
Locations: Houston Methodist Neal Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

NCT07423104

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +9 more
Locations: Not specified

View Trial Details

Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) trial results

Related conditions